Australian Broker Call

Produced and copyrighted by at www.fnarena.com

March 06, 2023

Access Broker Call Report Archives here

COMPANIES DISCUSSED IN THIS ISSUE

Click on symbol for fast access.

The number next to the symbol represents the number of brokers covering it for this report -(if more than 1).

Last Updated: 05:00 PM

Your daily news report on the latest recommendation, valuation, forecast and opinion changes.

This report includes concise but limited reviews of research recently published by Stockbrokers, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end.

For more info about the different terms used by stockbrokers, as well as the different methodologies behind similar sounding ratings, download our guide HERE

Today's Upgrades and Downgrades
NHC - New Hope Downgrade to Hold from Accumulate Ord Minnett
PME - Pro Medicus Upgrade to Neutral from Sell Citi
RGN - Region Group Upgrade to Neutral from Underperform Macquarie
SHL - Sonic Healthcare Upgrade to Buy from Neutral Citi
AMI  AURELIA METALS LIMITED

Gold & Silver

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.12

Ord Minnett rates AMI as Hold (3) -

In an important milestone towards securing funding, according to Ord Minnett, the NSW government has approved Aurelia Metals' Federation project (as expected).

The analyst suggests $110m will be needed to develop Federation.The project represents 32% of the broker's valuation for Aurelia Metals. This valuation includes a -60% risk discount.

The Hold rating is kept until Ord Minnett attains further clarity on funding. The target of 35c is unchanged.

Target price is $0.35 Current Price is $0.12 Difference: $0.235
If AMI meets the Ord Minnett target it will return approximately 204% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY23:

Ord Minnett forecasts a full year FY23 dividend of 0.00 cents and EPS of 0.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 57.50.

Forecast for FY24:

Ord Minnett forecasts a full year FY24 dividend of 0.00 cents and EPS of 2.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 4.42.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

ANZ  ANZ GROUP HOLDINGS LIMITED

Banks

More Research Tools In Stock Analysis - click HERE

Overnight Price: $23.85

Credit Suisse rates ANZ as Outperform (1) -

After analysis of reporting season results for the Bank sector, Credit Suisse now sees increasing headwinds and has a clear preference for business over retail banks.

The broker lists several headwinds including increasing competitive pressures as asset growth slows and a rising cost of funding when banks refinance cheap funding from the Term Funding Facility.

Inflationary pressures on costs and asset quality concerns as consumers confront higher interest rates are additional reasons for caution around the sector, explain the analysts.

Outperform-rated ANZ Bank is the most preferred, followed by National Australia Bank, Westpac and CommBank. Target $29.

Target price is $29.00 Current Price is $23.85 Difference: $5.15
If ANZ meets the Credit Suisse target it will return approximately 22% (excluding dividends, fees and charges).

Current consensus price target is $28.09, suggesting upside of 16.1% (ex-dividends)

The company's fiscal year ends in September.

Forecast for FY23:

Credit Suisse forecasts a full year FY23 dividend of 164.00 cents and EPS of 252.00 cents.
At the last closing share price the estimated dividend yield is 6.88%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.46.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 237.8, implying annual growth of -4.9%.

Current consensus DPS estimate is 156.4, implying a prospective dividend yield of 6.5%.

Current consensus EPS estimate suggests the PER is 10.2.

Forecast for FY24:

Credit Suisse forecasts a full year FY24 dividend of 173.00 cents and EPS of 266.00 cents.
At the last closing share price the estimated dividend yield is 7.25%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.97.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 239.2, implying annual growth of 0.6%.

Current consensus DPS estimate is 162.3, implying a prospective dividend yield of 6.7%.

Current consensus EPS estimate suggests the PER is 10.1.

Market Sentiment: 0.6

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

BEN  BENDIGO & ADELAIDE BANK LIMITED

Banks

More Research Tools In Stock Analysis - click HERE

Overnight Price: $9.60

Citi rates BEN as Neutral (3) -

In the wake of ANZ Bank's acquisition of Suncorp's bank, and Bank Of Queensland's acquisition of ME Bank, speculation is again mounting of a merger between Bank of Queensland and Bendigo & Adelaide Bank, which individually are way smaller than the majors.

A "merger of equals" would create a fifth pillar, but given the recent strategies implemented by each to remain standalone, Citi doesn't see it.

Neutral retained on both. Target 10.40 for Bendelaide.

Target price is $10.40 Current Price is $9.60 Difference: $0.8
If BEN meets the Citi target it will return approximately 8% (excluding dividends, fees and charges).

Current consensus price target is $10.37, suggesting upside of 9.8% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY23:

Citi forecasts a full year FY23 dividend of 60.00 cents and EPS of 94.80 cents.
At the last closing share price the estimated dividend yield is 6.25%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.13.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 93.5, implying annual growth of 6.8%.

Current consensus DPS estimate is 60.0, implying a prospective dividend yield of 6.4%.

Current consensus EPS estimate suggests the PER is 10.1.

Forecast for FY24:

Citi forecasts a full year FY24 dividend of 62.00 cents and EPS of 93.60 cents.
At the last closing share price the estimated dividend yield is 6.46%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.26.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 88.8, implying annual growth of -5.0%.

Current consensus DPS estimate is 60.8, implying a prospective dividend yield of 6.4%.

Current consensus EPS estimate suggests the PER is 10.6.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

BHP  BHP GROUP LIMITED

Bulks

More Research Tools In Stock Analysis - click HERE

Overnight Price: $48.32

UBS rates BHP as Sell (5) -

Having lobbed a $28.25/share bid for OZ Minerals ((OZL)), the independent expert review has concluded BHP Group's offer is "fair and reasonable" with a value assessment of between $27.37 and $30.47/share.

UBS regards the offer as a low-risk transaction that aligns with BHP's stated objective to increase future-facing commodities within its portfolio.

The next steps in the process are the April 13 Scheme meeting and the April 18 lodgement date with ASIC.

The Sell rating and $39 target are unchanged.

Target price is $39.00 Current Price is $48.32 Difference: minus $9.32 (current price is over target).
If BHP meets the UBS target it will return approximately minus 19% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $43.90, suggesting downside of -9.2% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY23:

UBS forecasts a full year FY23 dividend of 262.09 cents and EPS of 372.14 cents.
At the last closing share price the estimated dividend yield is 5.42%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.98.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 432.7, implying annual growth of N/A.

Current consensus DPS estimate is 279.9, implying a prospective dividend yield of 5.8%.

Current consensus EPS estimate suggests the PER is 11.2.

Forecast for FY24:

UBS forecasts a full year FY24 dividend of 250.51 cents and EPS of 357.66 cents.
At the last closing share price the estimated dividend yield is 5.18%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.51.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 437.4, implying annual growth of 1.1%.

Current consensus DPS estimate is 302.5, implying a prospective dividend yield of 6.3%.

Current consensus EPS estimate suggests the PER is 11.1.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

BOQ  BANK OF QUEENSLAND LIMITED

Banks

More Research Tools In Stock Analysis - click HERE

Overnight Price: $6.81

Citi rates BOQ as Neutral (3) -

In the wake of ANZ Bank's acquisition of Suncorp's bank, and Bank Of Queensland's acquisition of ME Bank, speculation is again mounting of a merger between Bank of Queensland and Bendigo & Adelaide Bank, which individually are way smaller than the majors.

A "merger of equals" would create a fifth pillar, but given the recent strategies implemented by each to remain standalone, Citi doesn't see it.

Neutral retained on both. Target $7.30 for Bank of Qld.

Target price is $7.30 Current Price is $6.81 Difference: $0.49
If BOQ meets the Citi target it will return approximately 7% (excluding dividends, fees and charges).

Current consensus price target is $7.63, suggesting upside of 10.2% (ex-dividends)

The company's fiscal year ends in August.

Forecast for FY23:

Citi forecasts a full year FY23 dividend of 54.00 cents and EPS of 85.80 cents.
At the last closing share price the estimated dividend yield is 7.93%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.94.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 77.7, implying annual growth of 17.2%.

Current consensus DPS estimate is 51.0, implying a prospective dividend yield of 7.4%.

Current consensus EPS estimate suggests the PER is 8.9.

Forecast for FY24:

Citi forecasts a full year FY24 dividend of 56.00 cents and EPS of 77.70 cents.
At the last closing share price the estimated dividend yield is 8.22%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.76.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 74.5, implying annual growth of -4.1%.

Current consensus DPS estimate is 51.8, implying a prospective dividend yield of 7.5%.

Current consensus EPS estimate suggests the PER is 9.3.

Market Sentiment: -0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CBA  COMMONWEALTH BANK OF AUSTRALIA

Banks

More Research Tools In Stock Analysis - click HERE

Overnight Price: $97.75

Credit Suisse rates CBA as Underperform (5) -

After analysis of reporting season results for the Bank sector, Credit Suisse now sees increasing headwinds and has a clear preference for business over retail banks.

The broker lists several headwinds including increasing competitive pressures as asset growth slows and a rising cost of funding when banks refinance cheap funding from the Term Funding Facility.

Inflationary pressures on costs and asset quality concerns as consumers confront higher interest rates are additional reasons for caution around the sector, explain the analysts.

CommBank is ranked last behind Westpac, National Australia Bank and the most-preferred ANZ Bank. Target $93.

Target price is $93.00 Current Price is $97.75 Difference: minus $4.75 (current price is over target).
If CBA meets the Credit Suisse target it will return approximately minus 5% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $91.66, suggesting downside of -7.0% (ex-dividends)

Forecast for FY23:

Current consensus EPS estimate is 611.9, implying annual growth of -2.2%.

Current consensus DPS estimate is 429.5, implying a prospective dividend yield of 4.4%.

Current consensus EPS estimate suggests the PER is 16.1.

Forecast for FY24:

Current consensus EPS estimate is 607.6, implying annual growth of -0.7%.

Current consensus DPS estimate is 453.8, implying a prospective dividend yield of 4.6%.

Current consensus EPS estimate suggests the PER is 16.2.

Market Sentiment: -0.6

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

LM8  LUNNON METALS LIMITED

Mining

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.96

Macquarie rates LM8 as Outperform (1) -

Lunnon Metals has reconfirmed historical essay results at its Silver Lake-Fisher project through more than 4,100 re-essays, confirming suitability for the company's exploration.  

While already holding a significant resource inventory, Silver Lake Hanging Wall, where surface diamond drilling in now expected to commence, and Warren offer potential to increase total resource. 

The Outperform rating and target price of $1.30 are retained.

Target price is $1.30 Current Price is $0.96 Difference: $0.345
If LM8 meets the Macquarie target it will return approximately 36% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY23:

Macquarie forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 5.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 16.75.

Forecast for FY24:

Macquarie forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 1.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 86.82.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

NAB  NATIONAL AUSTRALIA BANK LIMITED

Banks

More Research Tools In Stock Analysis - click HERE

Overnight Price: $29.15

Credit Suisse rates NAB as Neutral (3) -

After analysis of reporting season results for the Bank sector, Credit Suisse now sees increasing headwinds and has a clear preference for business over retail banks.

The broker lists several headwinds including increasing competitive pressures as asset growth slows and a rising cost of funding when banks refinance cheap funding from the Term Funding Facility.

Inflationary pressures on costs and asset quality concerns as consumers confront higher interest rates are additional reasons for caution around the sector, explain the analysts.

National Australia Bank is ranked second by Credit Suisse behind ANZ Bank, but ahead of Westpac and CommBank. Target $31.

Target price is $31.00 Current Price is $29.15 Difference: $1.85
If NAB meets the Credit Suisse target it will return approximately 6% (excluding dividends, fees and charges).

Current consensus price target is $31.20, suggesting upside of 5.9% (ex-dividends)

Forecast for FY23:

Current consensus EPS estimate is 246.1, implying annual growth of 15.0%.

Current consensus DPS estimate is 171.7, implying a prospective dividend yield of 5.8%.

Current consensus EPS estimate suggests the PER is 12.0.

Forecast for FY24:

Current consensus EPS estimate is 243.9, implying annual growth of -0.9%.

Current consensus DPS estimate is 177.0, implying a prospective dividend yield of 6.0%.

Current consensus EPS estimate suggests the PER is 12.1.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

NHC  NEW HOPE CORPORATION LIMITED

Coal

More Research Tools In Stock Analysis - click HERE

Overnight Price: $5.77

Ord Minnett rates NHC as Downgrade to Hold from Accumulate (3) -

Following New Hope's recent share price rally, Ord Minnett pulls-back its rating to Hold from Accumulate on valuation. 

No changes are made to forecasts and the broker's $6.50 target is maintained.

Target price is $6.50 Current Price is $5.77 Difference: $0.73
If NHC meets the Ord Minnett target it will return approximately 13% (excluding dividends, fees and charges).

Current consensus price target is $6.32, suggesting upside of 12.7% (ex-dividends)

The company's fiscal year ends in July.

Forecast for FY23:

Ord Minnett forecasts a full year FY23 dividend of 73.00 cents and EPS of 146.60 cents.
At the last closing share price the estimated dividend yield is 12.65%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 3.94.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 171.6, implying annual growth of 45.3%.

Current consensus DPS estimate is 109.0, implying a prospective dividend yield of 19.4%.

Current consensus EPS estimate suggests the PER is 3.3.

Forecast for FY24:

Ord Minnett forecasts a full year FY24 dividend of 64.00 cents and EPS of 126.30 cents.
At the last closing share price the estimated dividend yield is 11.09%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 4.57.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 171.6, implying annual growth of N/A.

Current consensus DPS estimate is 108.0, implying a prospective dividend yield of 19.3%.

Current consensus EPS estimate suggests the PER is 3.3.

Market Sentiment: 0.8

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

NTD  NATIONAL TYRE & WHEEL LIMITED

Transportation & Logistics

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.55

Morgans rates NTD as Hold (3) -

National Tyre & Wheel beat recent guidance with a gross margin of 27.1%, ahead of the 26.5% expected last December by management. 

The company anticipates further gross margin improvement in the 2H. While freight rates are now lower and supply costs have eased, management noted a mixed demand outlook (weaker consumer/strong commercial). Cost cutting measures will be implemented.

Morgans is cautious on the balance sheet given the weaker consumer backdrop and awaits greater earnings visibilty before upgrading from its current Hold rating. The target rises to 73c from 68c.

Target price is $0.73 Current Price is $0.55 Difference: $0.185
If NTD meets the Morgans target it will return approximately 34% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY23:

Morgans forecasts a full year FY23 dividend of 1.70 cents and EPS of 6.00 cents.
At the last closing share price the estimated dividend yield is 3.12%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.08.

Forecast for FY24:

Morgans forecasts a full year FY24 dividend of 3.00 cents and EPS of 9.00 cents.
At the last closing share price the estimated dividend yield is 5.50%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.06.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

NUF  NUFARM LIMITED

Agriculture

More Research Tools In Stock Analysis - click HERE

Overnight Price: $5.74

Citi rates NUF as Buy (1) -

The US Department of Agriculture's recent 2023 US outlook forum suggests a strong US ag market, Citi notes. USDA projects a 3% year on year increase in combined corn, soybean and wheat acreages in 2023. Key crop prices are expected to moderate, but remain higher than last ten year average.

While high interest rates, input cost inflation, tight supply chains, the ongoing conflict in Ukraine, and weather remain as key near-term risks, the broker views current crop and farmer’s economics as favorable for Nufarm and retains a Buy rating and $6.90 target.

Target price is $6.90 Current Price is $5.74 Difference: $1.16
If NUF meets the Citi target it will return approximately 20% (excluding dividends, fees and charges).

Current consensus price target is $7.02, suggesting upside of 22.9% (ex-dividends)

The company's fiscal year ends in September.

Forecast for FY23:

Citi forecasts a full year FY23 dividend of 11.00 cents and EPS of 36.20 cents.
At the last closing share price the estimated dividend yield is 1.92%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.86.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 39.3, implying annual growth of 49.4%.

Current consensus DPS estimate is 11.6, implying a prospective dividend yield of 2.0%.

Current consensus EPS estimate suggests the PER is 14.5.

Forecast for FY24:

Citi forecasts a full year FY24 dividend of 12.00 cents and EPS of 42.50 cents.
At the last closing share price the estimated dividend yield is 2.09%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.51.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 43.0, implying annual growth of 9.4%.

Current consensus DPS estimate is 12.6, implying a prospective dividend yield of 2.2%.

Current consensus EPS estimate suggests the PER is 13.3.

Market Sentiment: 0.6

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PME  PRO MEDICUS LIMITED

Medical Equipment & Devices

More Research Tools In Stock Analysis - click HERE

Overnight Price: $60.09

Citi rates PME as Upgrade to Neutral from Sell (3) -

Citi views Pro Medicus' business model as attractive, given a real competitive advantage in the Picture Archiving & Communication Systems space, but a valuation of some 70x PE on FY25 forecasts is keeping the broker on the sideline.

Citi does not yet explicitly forecast any contribution from Cardiology or AI, awaiting more details on the new products, nor any significant revenue contribution from Europe. These could be sources of upside over the medium to longer term, but difficult to quantify at this stage, the broker notes.

But following an -8% share price decline post-result, the broker upgrades to Neutral from Sell. Target unchanged at $61.

Target price is $61.00 Current Price is $60.09 Difference: $0.91
If PME meets the Citi target it will return approximately 2% (excluding dividends, fees and charges).

Current consensus price target is $50.28, suggesting downside of -17.5% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY23:

Citi forecasts a full year FY23 dividend of 26.80 cents and EPS of 53.50 cents.
At the last closing share price the estimated dividend yield is 0.45%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 112.32.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 53.8, implying annual growth of 26.3%.

Current consensus DPS estimate is 25.9, implying a prospective dividend yield of 0.4%.

Current consensus EPS estimate suggests the PER is 113.3.

Forecast for FY24:

Citi forecasts a full year FY24 dividend of 33.10 cents and EPS of 66.20 cents.
At the last closing share price the estimated dividend yield is 0.55%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 90.77.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 66.4, implying annual growth of 23.4%.

Current consensus DPS estimate is 32.0, implying a prospective dividend yield of 0.5%.

Current consensus EPS estimate suggests the PER is 91.8.

Market Sentiment: -0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PPH  PUSHPAY HOLDINGS LIMITED

Software & Services

More Research Tools In Stock Analysis - click HERE

Overnight Price: $1.11

Ord Minnett rates PPH as Hold (3) -

Ord Minnett is surprised Pushpay Holdings shareholders didn't pass the scheme of arrangement to allow the $1.34/share takeover by Pegasus Bidco.

The analyst believes Pegasus Bidco will return with a higher offer which will likely be below $1.37, the top-end of the independent adviser's valuation range.

The Hold rating and $1.20 target are unchanged.

Target price is $1.20 Current Price is $1.11 Difference: $0.093
If PPH meets the Ord Minnett target it will return approximately 8% (excluding dividends, fees and charges).

The company's fiscal year ends in March.

Forecast for FY23:

Ord Minnett forecasts a full year FY23 dividend of 0.00 cents and EPS of 5.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.12.

Forecast for FY24:

Ord Minnett forecasts a full year FY24 dividend of 0.00 cents and EPS of 5.65 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.60.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

RGN  REGION GROUP

REITs

More Research Tools In Stock Analysis - click HERE

Overnight Price: $2.50

Macquarie rates RGN as Upgrade to Neutral from Underperform (3) -

Highlighting that Region Group has underperformed the ASX200 A-REIT index by -6% since releasing its first half result, Macquarie notes it remains cautious on the company's earnings trajectory, particularly heading into FY24. 

The broker does remain positive on the company's defensive topline, with Region Group's tenant base performing strongly in the first half and leasing spreads improving to 4.4% from 3.3% partially as a result of the company delaying lease negotiations during covid-impacted periods. 

The rating is upgraded to Neutral from Underperform and the target price of $2.52 is retained.

Target price is $2.52 Current Price is $2.50 Difference: $0.02
If RGN meets the Macquarie target it will return approximately 1% (excluding dividends, fees and charges).

Current consensus price target is $2.77, suggesting upside of 11.0% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY23:

Macquarie forecasts a full year FY23 dividend of 15.20 cents and EPS of 14.70 cents.
At the last closing share price the estimated dividend yield is 6.08%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.01.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 16.4, implying annual growth of -62.7%.

Current consensus DPS estimate is 15.1, implying a prospective dividend yield of 6.1%.

Current consensus EPS estimate suggests the PER is 15.2.

Forecast for FY24:

Macquarie forecasts a full year FY24 dividend of 14.50 cents and EPS of 14.20 cents.
At the last closing share price the estimated dividend yield is 5.80%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.61.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 16.4, implying annual growth of N/A.

Current consensus DPS estimate is 15.2, implying a prospective dividend yield of 6.1%.

Current consensus EPS estimate suggests the PER is 15.2.

Market Sentiment: 0.2

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

SHL  SONIC HEALTHCARE LIMITED

Healthcare services

More Research Tools In Stock Analysis - click HERE

Overnight Price: $32.32

Citi rates SHL as Upgrade to Buy from Neutral (1) -

Citi has upgraded its earnings forecasts for Sonic Healthcare after adjusting for the AUDUSD, and rolled forward its valuation. The result is a target increase to $36.00 from $34.50 and an upgrade to Buy from Neutral.

The broker notes ample balance sheet capacity for acquisitions/new contracts or share buybacks and further upgrades its FY23-25 forecasts on higher margin expectations.

Target price is $36.00 Current Price is $32.32 Difference: $3.68
If SHL meets the Citi target it will return approximately 11% (excluding dividends, fees and charges).

Current consensus price target is $34.81, suggesting upside of 5.1% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY23:

Citi forecasts a full year FY23 dividend of 97.00 cents and EPS of 159.00 cents.
At the last closing share price the estimated dividend yield is 3.00%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.33.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 152.4, implying annual growth of -50.1%.

Current consensus DPS estimate is 95.5, implying a prospective dividend yield of 2.9%.

Current consensus EPS estimate suggests the PER is 21.7.

Forecast for FY24:

Citi forecasts a full year FY24 dividend of 111.00 cents and EPS of 153.00 cents.
At the last closing share price the estimated dividend yield is 3.43%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.12.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 148.4, implying annual growth of -2.6%.

Current consensus DPS estimate is 104.4, implying a prospective dividend yield of 3.2%.

Current consensus EPS estimate suggests the PER is 22.3.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

TWE  TREASURY WINE ESTATES LIMITED

Food, Beverages & Tobacco

More Research Tools In Stock Analysis - click HERE

Overnight Price: $13.58

UBS rates TWE as Buy (1) -

UBS anticipates 25% group earnings (EBITS) margins will be reiterated by management at upcoming investor days on March 8 and 9, while no trading update is expected.

The analyst will be ready with questions on the progress for Penfolds global distribution opportunity and the potential uplift from a China tourism recovery and future changes in duties.

The $15 target and Buy rating are unchanged.

Target price is $15.00 Current Price is $13.58 Difference: $1.42
If TWE meets the UBS target it will return approximately 10% (excluding dividends, fees and charges).

Current consensus price target is $14.16, suggesting upside of 4.9% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY23:

UBS forecasts a full year FY23 dividend of 35.00 cents and EPS of 48.00 cents.
At the last closing share price the estimated dividend yield is 2.58%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 28.29.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 50.8, implying annual growth of 39.3%.

Current consensus DPS estimate is 35.2, implying a prospective dividend yield of 2.6%.

Current consensus EPS estimate suggests the PER is 26.6.

Forecast for FY24:

UBS forecasts a full year FY24 dividend of 42.00 cents and EPS of 61.00 cents.
At the last closing share price the estimated dividend yield is 3.09%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 22.26.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 60.0, implying annual growth of 18.1%.

Current consensus DPS estimate is 40.9, implying a prospective dividend yield of 3.0%.

Current consensus EPS estimate suggests the PER is 22.5.

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

UMG  UNITED MALT GROUP LIMITED

Agriculture

More Research Tools In Stock Analysis - click HERE

Overnight Price: $3.43

Macquarie rates UMG as Outperform (1) -

Recent financial results have pointed to resilience in the beer industry, with trends largely in line with United Malt's performance according to Macquarie. According to the broker, brewers are benefiting from improved performance year-to-date after some softness in North American volumes in the December quarter. 

The broker feels recent guidance confirmation from United Malt has been an important driver of renewed market confidence, and sees a credible path to earnings recovery for the company through to FY24.

The Outperform rating and target price of $3.99 are retained.

Target price is $3.99 Current Price is $3.43 Difference: $0.56
If UMG meets the Macquarie target it will return approximately 16% (excluding dividends, fees and charges).

Current consensus price target is $3.86, suggesting upside of 14.0% (ex-dividends)

The company's fiscal year ends in September.

Forecast for FY23:

Macquarie forecasts a full year FY23 dividend of 4.10 cents and EPS of 10.30 cents.
At the last closing share price the estimated dividend yield is 1.20%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 33.30.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 10.8, implying annual growth of 178.4%.

Current consensus DPS estimate is 4.3, implying a prospective dividend yield of 1.3%.

Current consensus EPS estimate suggests the PER is 31.4.

Forecast for FY24:

Macquarie forecasts a full year FY24 dividend of 14.20 cents and EPS of 23.70 cents.
At the last closing share price the estimated dividend yield is 4.14%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.47.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 21.5, implying annual growth of 99.1%.

Current consensus DPS estimate is 13.1, implying a prospective dividend yield of 3.9%.

Current consensus EPS estimate suggests the PER is 15.8.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

WBC  WESTPAC BANKING CORPORATION

Banks

More Research Tools In Stock Analysis - click HERE

Overnight Price: $21.73

Credit Suisse rates WBC as Neutral (3) -

After analysis of reporting season results for the Bank sector, Credit Suisse now sees increasing headwinds and has a clear preference for business over retail banks.

The broker lists several headwinds including increasing competitive pressures as asset growth slows and a rising cost of funding when banks refinance cheap funding from the Term Funding Facility.

Inflationary pressures on costs and asset quality concerns as consumers confront higher interest rates are additional reasons for caution around the sector, explain the analysts.

ANZ Bank is the most preferred, followed by National Australia Bank, Westpac and CommBank. The Westpac target is $24.40.

Target price is $24.40 Current Price is $21.73 Difference: $2.67
If WBC meets the Credit Suisse target it will return approximately 12% (excluding dividends, fees and charges).

Current consensus price target is $26.24, suggesting upside of 18.7% (ex-dividends)

Forecast for FY23:

Current consensus EPS estimate is 212.3, implying annual growth of 32.8%.

Current consensus DPS estimate is 138.8, implying a prospective dividend yield of 6.3%.

Current consensus EPS estimate suggests the PER is 10.4.

Forecast for FY24:

Current consensus EPS estimate is 213.8, implying annual growth of 0.7%.

Current consensus DPS estimate is 148.0, implying a prospective dividend yield of 6.7%.

Current consensus EPS estimate suggests the PER is 10.3.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Today's Price Target Changes
Company Last Price Broker New Target Prev Target Change
NTD National Tyre & Wheel $0.56 Morgans 0.73 0.68 7.35%
NUF Nufarm $5.71 Citi 6.90 6.40 7.81%
PME Pro Medicus $60.96 Citi 61.00 55.00 10.91%
SHL Sonic Healthcare $33.13 Citi 36.00 34.50 4.35%
Summaries
AMI Aurelia Metals Hold - Ord Minnett Overnight Price $0.12
ANZ ANZ Bank Outperform - Credit Suisse Overnight Price $23.85
BEN Bendigo & Adelaide Bank Neutral - Citi Overnight Price $9.60
BHP BHP Group Sell - UBS Overnight Price $48.32
BOQ Bank of Queensland Neutral - Citi Overnight Price $6.81
CBA CommBank Underperform - Credit Suisse Overnight Price $97.75
LM8 Lunnon Metals Outperform - Macquarie Overnight Price $0.96
NAB National Australia Bank Neutral - Credit Suisse Overnight Price $29.15
NHC New Hope Downgrade to Hold from Accumulate - Ord Minnett Overnight Price $5.77
NTD National Tyre & Wheel Hold - Morgans Overnight Price $0.55
NUF Nufarm Buy - Citi Overnight Price $5.74
PME Pro Medicus Upgrade to Neutral from Sell - Citi Overnight Price $60.09
PPH Pushpay Holdings Hold - Ord Minnett Overnight Price $1.11
RGN Region Group Upgrade to Neutral from Underperform - Macquarie Overnight Price $2.50
SHL Sonic Healthcare Upgrade to Buy from Neutral - Citi Overnight Price $32.32
TWE Treasury Wine Estates Buy - UBS Overnight Price $13.58
UMG United Malt Outperform - Macquarie Overnight Price $3.43
WBC Westpac Neutral - Credit Suisse Overnight Price $21.73
RATING SUMMARY
Rating No. Of Recommendations
1. Buy

6

3. Hold

10

5. Sell

2

Monday 06 March 2023

Access Broker Call Report Archives here

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface. This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.